SCHEMBL1587526

SCHEMBL1587526

COc1ccc2cc(OC=O)ccc2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.56
CYP1A2 P05177 3/20 0.56
KDM4E B2RXH2 2/20 0.50
GSTP1 P09211 1/20 0.50
HSD17B1 P14061 1/20 0.48
HSD17B2 P37059 1/20 0.48
CBFB Q13951 1/20 0.48
ALDH1A1 P00352 3/20 0.47
PTGS1 P23219 3/20 0.46
AKR1C3 P42330 3/20 0.46
AKR1C2 P52895 3/20 0.46
NQO1 P15559 1/20 0.46
ERN1 O75460 1/20 0.46
TRIM24 O15164 1/20 0.46
TYR P14679 1/20 0.46
TRIM33 Q9UPN9 1/20 0.46
CYP1A1 P04798 1/20 0.45
CYP1B1 Q16678 1/20 0.45
PTGS2 P35354 3/20 0.44
CDC42 P60953 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28764686 0.96 CYP1A2 (0.57) CYP2A6CYP1A2KDM4EGSTP1HSD17B1
SCHEMBL8763499 0.89 CBFB (0.39) CYP2A6CYP1A2KDM4EGSTP1CBFB
SCHEMBL14876962 0.84 CYP1A2 (0.39) CYP2A6CYP1A2KDM4ECBFBTSHR
SCHEMBL98036 0.83 ACHE (0.50) CYP2A6CYP1A2ALDH1A1CYP1A1CYP1B1
SCHEMBL96668 0.81 ALDH1A1 (0.58) CYP2A6CYP1A2KDM4EALDH1A1TSHR
SCHEMBL4570685 0.81 CYP2A6 (0.54) CYP2A6CYP1A2KDM4ECBFBALDH1A1
SCHEMBL29447161 0.81 CYP1A2 (0.79) CYP2A6CYP1A2KDM4EGSTP1HSD17B1
SCHEMBL443070 0.81 CYP1A2 (0.79) CYP2A6CYP1A2KDM4EGSTP1HSD17B1
SCHEMBL97419 0.80 CYP1A2 (0.52) CYP2A6CYP1A2KDM4ECBFBPTGS1
SCHEMBL10254333 0.79 ALDH1A1 (0.43) CYP1A2ALDH1A1CYP1A1CYP1B1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180081274-A1 CATIONICALLY POLYMERIZABLE RESIST UNDERLAYER FILM-FORMING COMPOSITION NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2018-03-22 US disclosed
US-9728420-B2 Organic film composition, process for forming organic film, patterning process, and compound SHIN-ETSU CHEMICAL CO., LTD. (JP) 2017-08-08 US disclosed
US-20160336189-A1 ORGANIC FILM COMPOSITION, PROCESS FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND SHIN-ETSU CHEMICAL CO., LTD. (JP) 2016-11-17 US disclosed
US-20110092487-A1 NOVEL 3,8-DIAZA-BICYCLO[3.2.1]OCTANE-AND 3,9-DIAZA-BICYCLO[3.3.1]-NONANE-3-CARBOXYLIC ACID ESTER DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS NEUROSEARCH A/S (DK) 2011-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110092487-A1 NOVEL 3,8-DIAZA-BICYCLO[3.2.1]OCTANE-AND 3,9-DIAZA-BICYCLO[3.3.1]-NONANE-3-CARBOXYLIC ACID ESTER DERIVATIVES AND THEIR USE AS MONOAMINE NEUROTRANSMITTER RE-UPTAKE INHIBITORS SLC18A2, SLC6A2, SLC18A3 CYP2A6 283/4885CYP1A2 174/4885KDM4E 1272/4885
US-20160336189-A1 ORGANIC FILM COMPOSITION, PROCESS FOR FORMING ORGANIC FILM, PATTERNING PROCESS, AND COMPOUND CHRM1, CHRM2, POF1B CYP2A6 3390/4885CYP1A2 562/4885KDM4E 2762/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.